New search | Conferencedetail
Print view
 
 

Interstitial Lung Disease Drug Development Summit

Evvnt Promotion / evvnt
-
27.04.2021 - 29.04.2021  Online
Time: 09:00 - 15:00
 
Conference themes
With the entire world's attention focused firmly on pulmonary fibrosis in the wake of COVID19 and the landmark INBUILD study dramatically overhauling the ILD drug development landscape, biopharma are finally on the cusp of developing and disseminating life-changing therapeutics for patients suffering with interstitial lung disease.
Professional congress organizer (PCO)
Hanson Wade
Notes
Speakers: Ahmad Nabhan, Postdoctoral Scholar, Genentech, Christina Wenglen, Head of Research, AnaMar, Craig Conoscenti, Medical Expert ILD Respiratory Clinical Development and Medical Affairs, Boehringer Ingelheim and more.
 

Enquiries and Registration:

https://go.evvnt.com/729096-2?pid=4832
Mr. Customer Service
 
Categories
General Medicine
Languages
English
Congress fees
Conference + Workshops Day - Industry: $2799.0, Conference Only - Industry: $1999.0, Workshop Day - Industry: $899.0, Conference + Workshops Day - Academic: $1899.0, Conference Only - Academic: $1299.0, Workshops Day - Academic: $699.0
Participants expected
1000
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International promotes access to education and training for all regardless of social, geographic and national borders."

Center of ExcellenceÄrztekammer für WienSwiss Tropical and Public Health InstituteCharité International AcademynewTreeAlumni Club Medizinische Universität WienHelix - Forschung & Beratung WienÖsterreichische Gesellschaft für Public Health